Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial

被引：0

作者：

Ruth M. de Tute

Gordon Cook

David A. Cairns

Julia M. Brown

Jamie Cavenagh

A. John Ashcroft

John A. Snowden

Kwee Yong

Eleni Tholouli

Matthew Jenner

Anna Hockaday

Mark T. Drayson

Treen C. M. Morris

Andy C. Rawstron

Roger G. Owen

机构：

[1] Leeds Teaching Hospitals Trust,Haematological Malignancy Diagnostic Service

[2] University of Leeds,Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research

[3] Barts & The London NHS Trust,Department of Haematology

[4] Mid-Yorks NHS Trust,Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust & Department of Endocrinology & Metabolism

[5] University of Sheffield,Department of Haematology

[6] University College London,Department of Clinical Haematology, Manchester Royal Infirmary

[7] Manchester Foundation Trust,undefined

[8] University Hospital Southampton NHS Foundation Trust,undefined

[9] Institute of Immunology and Immunotherapy University of Birmingham,undefined

[10] College of Myeloma,undefined

来源：

Bone Marrow Transplantation | 2024年 / 59卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：431 / 434

页数：3